These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24956560)

  • 1. Association of PARP-1, NF-κB, NF-κBIA and IL-6, IL-1β and TNF-α with Graves Disease and Graves Ophthalmopathy.
    Niyazoglu M; Baykara O; Koc A; Aydoğdu P; Onaran I; Dellal FD; Tasan E; Sultuybek GK
    Gene; 2014 Sep; 547(2):226-32. PubMed ID: 24956560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly (ADP-ribose) polymerase-1 (PARP-1) in Chinese patients with Graves' disease and Graves' ophthalmopathy.
    Wu T; Tang DR; Zhao L; Sun FY
    Can J Physiol Pharmacol; 2018 Jun; 96(6):556-561. PubMed ID: 28177666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.
    Koc A; Batar B; Celik O; Onaran I; Tasan E; Sultuybek GK
    Immunobiology; 2014 Jul; 219(7):531-6. PubMed ID: 24703107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and overexpression of PARP-1 in circulating mononuclear cells promote TNF-alpha and IL-6 expression in patients with unstable angina.
    Huang D; Yang CZ; Yao L; Wang Y; Liao YH; Huang K
    Arch Med Res; 2008 Nov; 39(8):775-84. PubMed ID: 18996291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graves' ophthalmopathy and gene polymorphisms in interleukin-1alpha, interleukin-1beta, interleukin-1 receptor and interleukin-1 receptor antagonist.
    Khalilzadeh O; Anvari M; Esteghamati A; Mahmoudi M; Tahvildari M; Rashidi A; Khosravi F; Amirzargar A
    Clin Exp Ophthalmol; 2009 Aug; 37(6):614-9. PubMed ID: 19702713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between interleukin-6 polymorphism and age-at-onset of type 1 diabetes. Epistatic influences of the tumor necrosis factor-alpha and interleukin-1beta polymorphisms.
    Hermann C; Krikovszky D; Füst G; Kovács M; Körner A; Szabó A; Vannay A; Madácsy L
    Eur Cytokine Netw; 2005 Dec; 16(4):277-81. PubMed ID: 16464741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
    Aydın AF; Develi-İş S; Doğru-Abbasoğlu S; Vural P; Ozderya A; Karadağ B; Uysal M
    Int Immunopharmacol; 2014 Jan; 18(1):198-202. PubMed ID: 24291390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes.
    Anvari M; Khalilzadeh O; Esteghamati A; Esfahani SA; Rashidi A; Etemadi A; Mahmoudi M; Amirzargar AA
    Eye (Lond); 2010 Jun; 24(6):1058-63. PubMed ID: 19798110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-α and interleukin-1β gene polymorphisms and risk of brain abscess in North Indian population.
    Mishra P; Prasad KN; Singh K; Bajpai A; Sahu RN; Ojha BK
    Cytokine; 2015 Sep; 75(1):159-64. PubMed ID: 26187330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The VDR gene confers a genetic predisposition to Graves' disease and Graves' ophthalmopathy in the Southwest Chinese Han population.
    Zhou F; Liang Z; Wang X; Tan G; Wei W; Zheng G; Ma X; Tian D; Li H; Yu H
    Gene; 2021 Aug; 793():145750. PubMed ID: 34077777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy.
    van Steensel L; Paridaens D; Dingjan GM; van Daele PL; van Hagen PM; Kuijpers RW; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1002-7. PubMed ID: 19797221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between interleukin 21 and Graves' disease.
    Jia HY; Zhang ZG; Gu XJ; Guo T; Cui B; Ning G; Zhao YJ
    Genet Mol Res; 2011 Oct; 10(4):3338-46. PubMed ID: 22057994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of poly (ADP-ribose) polymerase-1 and cytokines in acute renal injury in elderly Chinese patients with diabetes mellitus.
    Cao L; Liu Y; Zhang L; Wei Y
    Clin Interv Aging; 2017; 12():2039-2045. PubMed ID: 29238179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone.
    Antonelli A; Ferrari SM; Fallahi P; Piaggi S; Paolicchi A; Franceschini SS; Salvi M; Ferrannini E
    Metabolism; 2011 Feb; 60(2):277-83. PubMed ID: 20206950
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zhang M; Liu S; Xu J; Lv S; Fan Y; Zhang Y; Zhang Y; Wu Y; Su Y; Yu H; Song S; He J; Li H
    Curr Eye Res; 2020 Jul; 45(7):888-895. PubMed ID: 31869260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predisposition to Graves' disease and Graves' ophthalmopathy by genetic variants of IL2RA.
    Du J; Wang X; Tan G; Wei W; Zhou F; Liang Z; Li H; Yu H
    J Mol Med (Berl); 2021 Oct; 99(10):1487-1495. PubMed ID: 34287665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribose) polymerase 1 inhibition prevents interleukin-1β-induced inflammation in human osteoarthritic chondrocytes.
    Sun Y; Zhou L; Lv D; Liu H; He T; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2015 Jun; 47(6):422-30. PubMed ID: 25926140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
    Daroszewski J; Pawlak E; Karabon L; Frydecka I; Jonkisz A; Slowik M; Bolanowski M
    Eur J Endocrinol; 2009 Nov; 161(5):787-93. PubMed ID: 19734241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.
    Kurylowicz A; Hiromatsu Y; Jurecka-Lubieniecka B; Kula D; Kowalska M; Ichimura M; Koga H; Kaku H; Bar-Andziak E; Nauman J; Jarzab B; Ploski R; Bednarczuk T
    Genes Immun; 2007 Oct; 8(7):532-8. PubMed ID: 17690684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.